Related references
Note: Only part of the references are listed.Familial Hypercholesterolaemia in the Malaysian Community: Prevalence, Under-Detection and Under-Treatment
Yung-An Chua et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2021)
2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
Francois Mach et al.
RUSSIAN JOURNAL OF CARDIOLOGY (2020)
Comparative aspects of the care of familial hypercholesterolemia in the Ten Countries Study
Jing Pang et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Treatment Patterns and Lipid Profile in Patients with Familial Hypercholesterolemia in Japan
Tamio Teramoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
Antonio J. Vallejo-Vaz et al.
ATHEROSCLEROSIS (2018)
Knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia: The importance of professional training
Ahmad Baihaqi Azraii et al.
ATHEROSCLEROSIS (2018)
An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the Ten Countries Study
Jing Pang et al.
BMJ OPEN (2017)
Familial hypercholesterolaemia
Joep C. Defesche et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Diagnostic performance of various familial hypercholesterolaemia diagnostic criteria compared to Dutch lipid clinic criteria in an Asian population
Suraya Abdul-Razak et al.
BMC CARDIOVASCULAR DISORDERS (2017)
Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil
Pamela R. S. Silva et al.
ATHEROSCLEROSIS (2017)
Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan
Tamio Teramoto et al.
ATHEROSCLEROSIS (2016)
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Alberico L. Catapano et al.
ATHEROSCLEROSIS (2016)
Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions
Katrina L. Ellis et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
Amit V. Khera et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Statins in Familial Hypercholesterolemia Consequences for Coronary Artery Disease and All-Cause Mortality
Joost Besseling et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Joseph L. Goldstein et al.
CELL (2015)
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia
John J. P. Kastelein et al.
EUROPEAN HEART JOURNAL (2015)
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2015)
Diabetic dyslipidemia
Liya Wu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Statin treatment of children with familial hypercholesterolemia - Trying to balance incomplete evidence of long-term safety and clinical accountability: Are we approaching a consensus?
Alpo Vuorio et al.
ATHEROSCLEROSIS (2013)
Ezetimibe and bile acid sequestrants: impact on lipoprotein metabolism and beyond
Patrick Couture et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2013)
The clustering of cardiovascular disease risk factors and their impacts on annual medical expenditure in Japan: community-based cost analysis using Gamma regression models
Yoshitaka Murakami et al.
BMJ OPEN (2013)
Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey
Jeong Euy Park et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2012)
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Anne C. Goldberg et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials
A. Pandor et al.
JOURNAL OF INTERNAL MEDICINE (2009)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study
Jorie Versmissen et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Share Paper
